Cargando…
PRMT5 promotes epithelial‐mesenchymal transition via EGFR‐β‐catenin axis in pancreatic cancer cells
Protein arginine methyltransferase 5 (PRMT5) has been implicated in the development and progression of human cancers. However, few studies reveal its role in epithelial‐mesenchymal transition (EMT) of pancreatic cancer cells. In this study, we find that PRMT5 is up‐regulated in pancreatic cancer, an...
Autores principales: | Ge, Lu, Wang, Huizhi, Xu, Xiao, Zhou, Zhengrong, He, Junbo, Peng, Wanxin, Du, Fengyi, Zhang, Youli, Gong, Aihua, Xu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991680/ https://www.ncbi.nlm.nih.gov/pubmed/31851779 http://dx.doi.org/10.1111/jcmm.14894 |
Ejemplares similares
-
Methyl-CpG-binding protein 2 drives the Furin/TGF-β1/Smad axis to promote epithelial–mesenchymal transition in pancreatic cancer cells
por: Wang, Huizhi, et al.
Publicado: (2020) -
FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma
por: Zhang, Chunli, et al.
Publicado: (2018) -
Methyl-CpG-binding domain 3 inhibits epithelial–mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling
por: Xu, Min, et al.
Publicado: (2017) -
MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells
por: Xu, Min, et al.
Publicado: (2016) -
MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial-Mesenchymal Transition (EMT) Pathways
por: Ding, Yuntao, et al.
Publicado: (2023)